Orbimed Advisors Llc Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Orbimed Advisors Llc disclosed 98 stock positions valued at approximately $5.28B as of quarter-end June 30, 2026. The largest holdings include EDGEWISE THERAPEUTICS INC, ENLIVEN THERAPEUTICS INC, and ELI LILLY & CO.
- Report Period
- June 30, 2026
- No. of Stocks
- 98
- Portfolio Value
- $5.28B
Holdings by Sector
Orbimed Advisors Llc Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| EDGEWISE THERAPEUTICS INC | EWTX | Healthcare | 11.94% | 15,518,492 | - | - | $630,516,330 |
| ENLIVEN THERAPEUTICS INC | ELVN | Healthcare | 6.51% | 6,776,632 | -1,182,906 | -14.86% | $343,914,074 |
| ELI LILLY & CO | LLY | Healthcare | 5.86% | 257,900 | +21,100 | +8.91% | $309,332,997 |
| MBX BIOSCIENCES INC | MBX | Other | 3.58% | 3,428,736 | -209,151 | -5.75% | $189,266,227 |
| SINOVAC BIOTECH LTD | SVA | Other | 3.49% | 2,718,735 | - | - | $184,466,170 |
| STRUCTURE THERAPEUTICS INC | GPCR | Healthcare | 2.25% | 2,209,400 | +733,997 | +49.75% | $118,578,498 |
| SIONNA THERAPEUTICS INC | SION | Other | 2.13% | 2,555,877 | -974,825 | -27.61% | $112,433,029 |
| CORVUS PHARMACEUTICALS INC | CRVS | Healthcare | 2.03% | 7,165,006 | - | - | $107,045,190 |
| ARRIVENT BIOPHARMA INC | AVBP | Healthcare | 1.99% | 3,027,328 | - | - | $105,169,375 |
| GUARDANT HEALTH INC | GH | Healthcare | 1.66% | 583,700 | +148,500 | +34.12% | $87,572,511 |
| ARGENX SE | ARGX | Healthcare | 1.63% | 92,880 | -44,020 | -32.15% | $86,171,278 |
| MERCK & CO INC | MRK | Healthcare | 1.61% | 663,400 | - | - | $85,246,900 |
| UNIQURE NV | QURE | Other | 1.58% | 1,807,486 | -328,663 | -15.39% | $83,252,805 |
| PRAXIS PRECISION MEDICINES I | PRAX | Healthcare | 1.46% | 230,100 | +57,600 | +33.39% | $77,035,179 |
| EDWARDS LIFESCIENCES CORP | EW | Healthcare | 1.43% | 834,900 | -395,700 | -32.16% | $75,525,054 |
| PRELUDE THERAPEUTICS INC | PRLD | Healthcare | 1.39% | 13,724,571 | +2,815,315 | +25.81% | $73,151,963 |
| ABIVAX SA | ABVX | Healthcare | 1.38% | 546,522 | +80,822 | +17.35% | $72,829,522 |
| DYNE THERAPEUTICS INC | DYN | Healthcare | 1.36% | 3,235,684 | +317,800 | +10.89% | $71,864,542 |
| NATERA INC | NTRA | Healthcare | 1.35% | 262,000 | - | - | $71,119,900 |
| CG ONCOLOGY INC | CGON | Healthcare | 1.31% | 972,800 | +24,533 | +2.59% | $69,117,440 |
| UNITEDHEALTH GROUP INC | UNH | Healthcare | 1.27% | 161,100 | +161,100 | +100.00% | $66,957,993 |
| ARS PHARMACEUTICALS INC | SPRY | Healthcare | 1.26% | 8,288,510 | - | - | $66,390,965 |
| HUMANA INC | HUM | Healthcare | 1.23% | 164,100 | +164,100 | +100.00% | $65,183,802 |
| COGENT BIOSCIENCES INC | COGT | Healthcare | 1.23% | 1,681,300 | +1,359,200 | +421.98% | $65,066,310 |
| BOSTON SCIENTIFIC CORP | BSX | Healthcare | 1.20% | 1,483,200 | -898,900 | -37.74% | $63,302,976 |
| INTUITIVE SURGICAL INC | ISRG | Healthcare | 1.19% | 157,900 | -50,800 | -24.34% | $62,793,672 |
| MINERALYS THERAPEUTICS INC | MLYS | Healthcare | 1.08% | 2,110,300 | +57,400 | +2.80% | $56,935,894 |
| ODYSSEY THERAPEUTICS INC | ODTX | Other | 1.06% | 3,001,198 | +3,001,198 | +100.00% | $56,152,415 |
| XENON PHARMACEUTICALS INC | XENE | Healthcare | 1.02% | 892,471 | -167,500 | -15.80% | $53,869,550 |
| ARCUTIS BIOTHERAPEUTICS INC | ARQT | Healthcare | 1.01% | 2,042,000 | +2,042,000 | +100.00% | $53,541,240 |
Showing 30 of 98 holdings in the latest reporting period.
Orbimed Advisors Llc Options Holdings in Q2 2026
| Quarter | Symbol | Company | Option | Contracts | Notional Value |
|---|---|---|---|---|---|
| Q2 2026 | XBI | SPDR Series Trust SPDR S&P Bio | PUT | 300,000 | $47,475,000 |
| Q2 2026 | ABVX | Abivax SA | CALL | 200,000 | $26,652,000 |
| Q2 2026 | PTGX | Protagonist Therapeutics, Inc. | CALL | 150,000 | $18,387,000 |
| Q2 2026 | RVMD | Revolution Medicines, Inc. | CALL | 50,000 | $9,364,000 |
| Q2 2026 | PVLA | PALVELLA THERAPEUTICS, INC. | CALL | 40,000 | $6,112,800 |
| Q2 2026 | UNH | UnitedHealth Group Incorporated | CALL | 10,000 | $4,156,300 |
| Q2 2026 | ELV | Elevance Health, Inc. | CALL | 10,000 | $3,867,300 |
| Q2 2026 | SLS | SELLAS Life Sciences Group, Inc | PUT | 92,500 | $1,365,300 |
Showing 8 of 8 options positions in the latest reporting period.
Notional value represents the total exposure of the options position.